Figures & data
Figure 1 The activated partial thromboplastin time in donor groups with titer of anti-SARS-CoV-2 IgG in blood plasma, Index (S/C): 1–0; 2–75 ± 5; 3–85 ± 5. *p < 0.05; **p > 0.05.
![Figure 1 The activated partial thromboplastin time in donor groups with titer of anti-SARS-CoV-2 IgG in blood plasma, Index (S/C): 1–0; 2–75 ± 5; 3–85 ± 5. *p < 0.05; **p > 0.05.](/cms/asset/1ed34f9d-e0c8-4bcb-b9fb-3e3a281f1ef4/dijg_a_12299320_f0001_c.jpg)
Figure 2 The thrombin time in donor groups with titer of anti-SARS-CoV-2 IgG in blood plasma, Index (S/C): 1–0; 2–10 ± 3; 3–65 ± 5. *p < 0.05; **p > 0.05.
![Figure 2 The thrombin time in donor groups with titer of anti-SARS-CoV-2 IgG in blood plasma, Index (S/C): 1–0; 2–10 ± 3; 3–65 ± 5. *p < 0.05; **p > 0.05.](/cms/asset/b271c040-6d0a-46af-b471-750f21d54381/dijg_a_12299320_f0002_c.jpg)
Figure 3 The activity of ATIII in donor groups with titer of anti-SARS-CoV-2 IgG, Index (S/C): 1–0; 2–65 ± 5; 3–75 ± 5. *p < 0.05.
![Figure 3 The activity of ATIII in donor groups with titer of anti-SARS-CoV-2 IgG, Index (S/C): 1–0; 2–65 ± 5; 3–75 ± 5. *p < 0.05.](/cms/asset/9ae8375a-2d43-4cf6-af3f-93b2ae368498/dijg_a_12299320_f0003_c.jpg)
Figure 4 The concentration of ATIII in donor groups with titer of anti-SARS-CoV-2 IgG, Index (S/C): 1–0; 2–75 ± 5; 3–175 ± 5. *p < 0.05.
![Figure 4 The concentration of ATIII in donor groups with titer of anti-SARS-CoV-2 IgG, Index (S/C): 1–0; 2–75 ± 5; 3–175 ± 5. *p < 0.05.](/cms/asset/8c85f22f-670f-401f-9704-f6254feb556a/dijg_a_12299320_f0004_c.jpg)
Figure 5 The PC activity in donor groups with titer of anti-SARS-CoV-2 IgG, Index (S/C): 1–0; 2–55 ± 5; 3–95 ± 5. *p < 0.05.
![Figure 5 The PC activity in donor groups with titer of anti-SARS-CoV-2 IgG, Index (S/C): 1–0; 2–55 ± 5; 3–95 ± 5. *p < 0.05.](/cms/asset/61047ccc-1d50-48dc-bea5-3b9ef9870d90/dijg_a_12299320_f0005_c.jpg)